Prescription-drug middlemen face more pressure from FTC in new report

The Federal Trade Commission on Tuesday ramped up the pressure on prescription-drug middlemen who influence the accessibility and affordability of medications.

Previous post Largest U.S. banks may save billions on Fed surcharge: report
Next post Why Schwab’s stock is getting new respect from Wall Street analysts